• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2001年至2008年伊朗中部亚兹德省胃癌的五年生存率

Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008.

作者信息

Akhondi-Meybodi Mohsen, Ghane Marzieh, Akhondi-Meybodi Sara, Dashti Golnaz

机构信息

Associate Professor, Department of Internal Medicine, Subspecialty in Gastroenterology and Hepatology, ShahidSadoughi University of Medical Sciences, Yazd, Iran.

Medical Student, Member of Student Research Committee, ShahidSadoughi University of Medical Sciences, Yazd, Iran.

出版信息

Middle East J Dig Dis. 2017 Jan;9(1):39-48. doi: 10.15171/mejdd.2016.50.

DOI:10.15171/mejdd.2016.50
PMID:28316765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5308133/
Abstract

BACKGROUND The number of patients with gastric cancer is growing worldwide. In Iran (in 2009) of 74067 new cases of cancer, 6886 were diagnosed as having gastric cancer. This study was conducted to investigate 5-year survival rate for gastric cancer in Yazd province, central Iran. METHODS In this descriptive study, the medical records of patients with gastric cancer were collected from the archives of Yazd hospitals from 2001 to 2008. The data gathered included age, sex, type of histopathology, site of involvement, cancer staging, and mode of treatment, which were analyzed using SPSS software version 11.5. To investigate the survival and the factors influencing the survival time of patients, which are the main objectives of this study, Kaplan-Meier method was used and Cox proportional hazards model was fitted to the data. To compare survival function in different subgroups, the log rank test or generalized Wilcoxon test was used. RESULTS 295 cases of gastric cancer were enrolled in the study. The mean age of the subjects was 59.3 ± 9 years. 5-year survival rate of the patients was calculated as 18% where the highest rate was 39% for the age group of 50-60 years and the lowest was 3% for the age group of above 80 years. 5-year survival rates in different groups were as follows: 32% in women, 13% in men; 16% in adenocarcinoma, 46% in other pathologies; 16% in gastric cardia involvement, 17% in antrum; 59% in stage 1, 31% in stage 2, 13% in stage 3, and 3% in stage 4. CONCLUSION The results of this study showed that age, stage of the cancer, mode of therapy, and type of histopathology affected the survival rate of gastric cancer. No significant association was found between the site of involvement and survival rate. In general, the survival rate for gastric cancer was low, which might be due to slow but steady progress of the disease and delayed referral of the patients.

摘要

背景 全球胃癌患者数量正在增加。在伊朗(2009年),74067例新发癌症病例中,有6886例被诊断为胃癌。本研究旨在调查伊朗中部亚兹德省胃癌患者的5年生存率。方法 在这项描述性研究中,收集了2001年至2008年亚兹德医院档案中胃癌患者的病历。收集的数据包括年龄、性别、组织病理学类型、受累部位、癌症分期和治疗方式,使用SPSS 11.5软件进行分析。为了调查患者的生存率以及影响生存时间的因素(这是本研究的主要目的),采用了Kaplan-Meier方法,并对数据拟合Cox比例风险模型。为了比较不同亚组的生存函数,使用了对数秩检验或广义Wilcoxon检验。结果 本研究纳入了295例胃癌患者。受试者的平均年龄为59.³±9岁。患者的5年生存率计算为18%,其中50 - 60岁年龄组的最高生存率为39%,80岁以上年龄组的最低生存率为3%。不同组的5年生存率如下:女性为32%,男性为13%;腺癌为16%,其他病理类型为46%;贲门受累为16%,胃窦为17%;1期为59%,2期为31%,3期为13%,4期为3%。结论 本研究结果表明,年龄、癌症分期、治疗方式和组织病理学类型影响胃癌的生存率。未发现受累部位与生存率之间存在显著关联。总体而言,胃癌的生存率较低,这可能是由于疾病进展缓慢但持续以及患者转诊延迟所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/671f835d0e73/mejdd-9-39-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/042d3614d942/mejdd-9-39-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/407517e3cc0c/mejdd-9-39-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/d37d9c667356/mejdd-9-39-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/c9e709ee4157/mejdd-9-39-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/6db6b2b117dc/mejdd-9-39-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/dde3f5a69c00/mejdd-9-39-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/aabe84f6a960/mejdd-9-39-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/671f835d0e73/mejdd-9-39-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/042d3614d942/mejdd-9-39-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/407517e3cc0c/mejdd-9-39-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/d37d9c667356/mejdd-9-39-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/c9e709ee4157/mejdd-9-39-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/6db6b2b117dc/mejdd-9-39-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/dde3f5a69c00/mejdd-9-39-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/aabe84f6a960/mejdd-9-39-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf4/5308133/671f835d0e73/mejdd-9-39-g008.jpg

相似文献

1
Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008.2001年至2008年伊朗中部亚兹德省胃癌的五年生存率
Middle East J Dig Dis. 2017 Jan;9(1):39-48. doi: 10.15171/mejdd.2016.50.
2
Survival rate of patients with gastric cancer in Hormozgan Province, Iran.伊朗霍尔木兹甘省胃癌患者的生存率。
Med J Islam Repub Iran. 2019 Jul 24;33:74. doi: 10.34171/mjiri.33.74. eCollection 2019.
3
Estimating postoperative survival of gastric cancer patients and factors affecting it in Iran: Based on a TNM-7 Staging System.基于TNM-7分期系统评估伊朗胃癌患者的术后生存率及其影响因素
Acta Med Iran. 2016 Feb;54(2):114-8.
4
Five year survival of women with breast cancer in Yazd.亚兹德乳腺癌女性患者的五年生存率。
Asian Pac J Cancer Prev. 2014;15(16):6597-601. doi: 10.7314/apjcp.2014.15.16.6597.
5
[Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer].[血中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)在胃癌患者中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):910-5.
6
Results of combination chemotherapy and radiation therapy in non-metastatic gastric cancer in Yazd--Iran.
Indian J Cancer. 2015 Jan-Mar;52(1):40-3. doi: 10.4103/0019-509X.175583.
7
[Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].基于多中心、大容量数据库的胃癌手术治疗相关数据整合与分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Feb;19(2):179-85.
8
Survival of patients with lung cancer, Yazd, Iran.伊朗亚兹德肺癌患者的生存率
Asian Pac J Cancer Prev. 2012;13(9):4387-91. doi: 10.7314/apjcp.2012.13.9.4387.
9
Assessment of gastric cancer survival: using an artificial hierarchical neural network.胃癌生存率评估:使用人工分层神经网络
Pak J Biol Sci. 2008 Apr 15;11(8):1076-84. doi: 10.3923/pjbs.2008.1076.1084.
10
Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran.伊朗西北部阿尔达比勒省胃癌和食管癌的生存率
Arch Iran Med. 2007 Jan;10(1):32-7.

引用本文的文献

1
Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.胃癌中赖氨酰氧化酶表达的临床病理和预后价值:系统评价、荟萃分析和生物信息学分析。
Sci Rep. 2022 Oct 6;12(1):16786. doi: 10.1038/s41598-022-21402-1.
2
Influential Factors on Survival in Gastric Cancer: A Single-center Study.胃癌生存的影响因素:一项单中心研究
J Res Med Sci. 2022 Mar 17;27:19. doi: 10.4103/jrms.JRMS_1286_20. eCollection 2022.
3
EDIL3 regulates gastric cancer cell migration, invasion and epithelial-mesenchymal transition via TGF-β1/XIST/miR-137 feedback loop.

本文引用的文献

1
Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?胃癌辅助放化疗:我们应该使用预后因素来选择患者吗?
World J Gastroenterol. 2016 Jan 21;22(3):1131-8. doi: 10.3748/wjg.v22.i3.1131.
2
Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009.2005 - 2009年伊朗中部省份亚兹德的癌症流行病学与趋势
J Res Health Sci. 2014 Summer;14(3):210-3.
3
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.胃癌:描述性流行病学、风险因素、筛查与预防
EDIL3通过TGF-β1/XIST/miR-137反馈环调节胃癌细胞的迁移、侵袭和上皮-间质转化。
Transl Cancer Res. 2020 Oct;9(10):6313-6330. doi: 10.21037/tcr-19-2967b.
4
Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.CXCR4作为与胃癌肿瘤免疫微环境相关的预后生物标志物的作用。
Front Cell Dev Biol. 2021 Sep 8;9:654504. doi: 10.3389/fcell.2021.654504. eCollection 2021.
5
Automatic Detection of Gastric Wall Structure Based on Oral Contrast-Enhanced Ultrasound and Its Application on Tumor Screening.基于口服对比增强超声的胃壁结构自动检测及其在肿瘤筛查中的应用
Front Oncol. 2021 Mar 29;11:627556. doi: 10.3389/fonc.2021.627556. eCollection 2021.
6
Survival Time in Treatment Modalities of Gastric Carcinoma at King Khalid Hospital- Jeddah Saudi Arabia: a Retrospective Cohort Study.沙特阿拉伯吉达市哈立德国王医院胃癌治疗方式的生存时间:一项回顾性队列研究。
Mater Sociomed. 2020 Dec;32(4):271-276. doi: 10.5455/msm.2020.32.271-276.
7
miR-502-5p inhibits the proliferation, migration and invasion of gastric cancer cells by targeting SP1.微小RNA-502-5p通过靶向特异性蛋白1抑制胃癌细胞的增殖、迁移和侵袭。
Oncol Lett. 2020 Sep;20(3):2757-2762. doi: 10.3892/ol.2020.11808. Epub 2020 Jul 3.
8
Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K/AKT pathway.文拉法辛通过 PI3K/AKT 通路诱导胃癌 AGS 细胞凋亡和自噬。
FEBS Open Bio. 2020 Oct;10(10):2157-2165. doi: 10.1002/2211-5463.12944. Epub 2020 Sep 26.
9
HP-CagA+ Regulates the Expression of CDK4/CyclinD1 via to Change Cell Cycle and Promote Cell Proliferation.HP-CagA+ 通过 调控 CDK4/CyclinD1 的表达来改变细胞周期并促进细胞增殖。
Int J Mol Sci. 2019 Dec 28;21(1):224. doi: 10.3390/ijms21010224.
10
Economic Burden of Gastric Cancer: A Case of Iran.胃癌的经济负担:以伊朗为例。
Cancer Control. 2019 Jan-Dec;26(1):1073274819837185. doi: 10.1177/1073274819837185.
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13. doi: 10.1158/1055-9965.EPI-13-1057. Epub 2014 Mar 11.
4
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
5
Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.≥70 岁老年胃癌患者的特征和预后。
World J Gastroenterol. 2013 Oct 21;19(39):6568-78. doi: 10.3748/wjg.v19.i39.6568.
6
Gastric cancer in Ardabil, Iran--a review and update on cancer registry data.伊朗阿尔达比勒的胃癌——癌症登记数据的回顾与更新
Asian Pac J Cancer Prev. 2010;11(3):595-9.
7
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands.1990 年至 2007 年期间胃腺癌发病率、治疗和生存趋势:荷兰基于人群的研究。
Eur J Cancer. 2010 Apr;46(6):1101-10. doi: 10.1016/j.ejca.2010.02.013. Epub 2010 Mar 8.
8
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.放疗对可切除胃癌患者生存的影响:文献数据的荟萃分析
Cancer Treat Rev. 2007 Dec;33(8):729-40. doi: 10.1016/j.ctrv.2007.08.005. Epub 2007 Nov 1.
9
[Prognostic factors in gastric cancer. Our experience and review of the literature].
Minerva Chir. 2000 May;55(5):299-305.
10
The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.美国国立癌症数据库关于接受胃切除术的美国胃癌患者生存率低的报告:第五版美国癌症联合委员会分期、近端疾病及“不同疾病”假说
Cancer. 2000 Feb 15;88(4):921-32.